B
Biogena
Focusing on products and services that help everyone around the world to achieve better health and well-being and the best possible development of their potential
At a glance
- Founded
- 2006
- Headquarters
- Salzburg, Austria
- Sector
- Biotech & Life Sciences
- Outcome tier
- Colt$25–100M revenue
Knowledge graph
News
More headlines
Open roles
Biogena in the Salzburg ecosystem
The Biogena office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- INInvesdor
Series B and later1 investor entered at this stage
- TCTauros Capital
Source: Dealroom Talent Intelligence.
Global footprint
across markets
Investments and acquisitions
Disclosed deals where Biogena was the backer or acquirer, 2021–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
5 deals across Biogena's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Biogena's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biogena on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biogena on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

